Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 96, Issue 3-4, 2005, Pages 251-258

  Hååg, Petra ^a   Bektic, Jasmin ^a   Bartsch, Georg ^a   Klocker, Helmut ^a   Eder, Iris E ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Androgen independent prostate cancer; Androgen receptor; Gene expression analysis; siRNA

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CYCLIN D1; PROTEIN P21; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIVITY; GENE EXPRESSION PROFILING; GENE INDUCTION; GENE SWITCHING; HORMONE DEPENDENCE; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; PROSTATE ADENOCARCINOMA; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REFRACTORY PERIOD; REGULATOR GENE;

ANDROGENS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 23144434218     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.04.029     Document Type: Article

References (26)

1. E.D. Crawford, M.A. Eisenberger, D.G. McLeod, J.T. Spaulding, R. Benson, F.A. Dorr, B.A. Blumenstein, M.A. Davis, and P.J.A. Goodman A controlled trial of leuprolide with and without flutamide in prostatic carcinoma N. Engl. J. Med. 321 1989 419 424
2. A.G. Rosenberg, and A.C. von Eschenbach Hormonal therapy for prostate cancer Semin. Surg. Oncol. 6 1990 71 76
3. N. Kyprianou, H.F. English, and J.T. Isaacs Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation Cancer Res. 50 1990 3748 3753
4. J. Veldscholte, C.A. Berrevoets, A.O. Brinkmann, A. Grootegoed, and E. Mulder Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat shock protein interaction, and transcription activation Biochemistry 31 1992 2393 2399
5. M. Truss, and M. Beato Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors Endocr. Rev. 14 1993 459 479
6. M.J. Tsai, and B.W. O'Malley Molecular mechanisms of action of steroid/thyroid receptor superfamily members Ann. Rev. Biochem. 63 451-486 1994
7. A. Hobisch, Z. Culig, C. Radmayr, G. Bartsch, H. Klocker, and A. Hittmair Distant metastases from prostatic carcinoma express androgen receptor protein Cancer Res. 55 1995 3068 3072
8. T. Visakorpi, E. Hyytinen, P. Koivisto, M. Tanner, R. Keinänen, C. Palmberg, A. Palotie, T. Tammela, J. Isola, and O.-P. Kallioniemi In vivo amplification of the androgen receptor gene and progression of human prostate cancer Nat. Genet. 9 1995 401 406
9. Z. Culig, A. Hobisch, M.V. Cronauer, C. Radmayr, J. Trapman, A. Hittmair, G. Bartsch, and H. Klocker Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor Cancer Res. 54 1994 5474 5478
10. L.V. Nazareth, and N.L. Weigel Activation of the human androgen receptor through a protein kinase A signaling pathway J. Biol. Chem. 271 33 1996 19900 19907
11. I.E. Eder, Z. Culig, R. Ramoner, M. Thurnher, T. Putz, C. Nessler-Menardi, M. Tiefenthaler, G. Bartsch, and H. Klocker Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides Cancer Gene Ther. 7 7 2000 997 1007
12. I.E. Eder, J. Hoffmann, H. Rogatsch, G. Schäfer, D. Zopf, G. Bartsch, and H. Klocker Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor Cancer Gene Ther. 9 2002 117 125
13. Z. Culig, J. Hoffmann, M. Erdel, I.E. Eder, A. Hobisch, A. Hittmair, G. Bartsch, G. Utermann, M.R. Schneider, K. Parczyk, and H. Klocker Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system Br. J. Cancer 81 1999 242 251
14. K. Pfeil, I.E. Eder, T. Putz, R. Ramoner, Z. Culig, F. Ueberall, G. Bartsch, and H. Klocker Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells Prostate 58 3 2004 259 268
15. T. Tuschl Expanding small RNA interference Nat. Biotechnol. 20 2002 446 448
16. B. Bilanges, and D. Stokoe Direct comparison of the specificity of gene silencing using antisense and RNAi Biochem. J. 2005
17. F. Hamy, V. Brondani, R. Spoerri, S. Rigo, C. Stamm, and T. Klimkait Specific block of androgen receptor activity by antisense oligonucleotides Prostate Cancer Prostatic Dis. 6 1 2003 27 33
18. Y.-J. Ko, G.R. Devi, C.A. London, A. Kayas, M.T. Reddy, P.L. Iversen, G.J. Bubley, and S.P. Balk Androgen receptor down regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers J. Urol. 172 2004 1140 1144
19. O.L. Zegarra-Moro, L.J. Schmidt, H. Huang, and D.J. Tindall Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells Cancer Res. 62 2002 1008 1013
20. C.D. Chen, D.S. Welsbie, C. Tran, S.H. Baek, R. Chen, R. Vessella, M.G. Rosenfeld, and C.L. Sawyers Molecular determinants of resistance to antiandrogen therapy Nat. Med. 10 1 2004 33 39
21. J. Knillova, Z. Kolar, and A. Hlobilkova The significance of key regulators of apoptosis in the development and prognosis of prostate carcinoma. II. Products of suppressor genes Rb and PTEN, CDKI, Fas Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech Repub. 147 1 2003 11 17
22. Y. Xiong, G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach p21 is a universal inhibitor of cyclin kinases Nature 366 6456 1993 701 704
23. X. Gao, Y.Q. Chen, N. Wu, D.J. Grignon, W. Sakr, A.T. Porter, and K.V. Honn Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer Oncogene 11 7 1995 1395 1398
24. L.G. Wang, L. Ossowski, and A.C. Ferrari Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line Cancer Res. 61 20 2001 7544 7551
25. C.E. Petre-Draviam, S.L. Cook, C.J. Burd, T.W. Marshall, Y.B. Wetherill, and K.E. Knudsen Specificity of cyclin D1 for androgen receptor regulation Cancer Res. 63 16 2003 4903 4913
26. L.A. Maddison, W.J. Huss, R.M. Barrios, and N.M. Greenberg Differential expression of cell cycle regulatory molecules and evidence for a "cyclin switch" during progression of prostate cancer Prostate 58 4 2004 335 344